
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Author(s) -
Dapeng Li,
Robert J. Edwards,
Kartik Manne,
David R. Martinez,
Alexandra Schäfer,
S. Munir Alam,
Kevin Wiehe,
Xin Lu,
Robert E. Parks,
Laura L. Sutherland,
Thomas Oguin,
Charlene McDanal,
Lautaro G. Perez,
Katayoun Mansouri,
S. Gobeil,
Katarzyna J. Janowska,
Victoria Stalls,
M. Kopp,
Fangping Cai,
Esther Lee,
Andrew Foulger,
Giovanna Hernandéz,
Aja Sanzone,
Kedamawit Tilahun,
Chuancang Jiang,
Longping V. Tse,
Kevin W. Bock,
Mahnaz Minai,
Bianca M. Nagata,
Kenneth Cronin,
Victoria Gee-Lai,
Margaret Deyton,
Maggie Barr,
Tarra Von Holle,
Andrew N. Macintyre,
Erica Stover,
Jared Feldman,
Blake M. Hauser,
Timothy M. Caradonna,
Trevor Scobey,
Wes Rountree,
Yunfei Wang,
M. Anthony Moody,
Derek W. Cain,
C. Todd DeMarco,
Thomas N. Denny,
Christopher W. Woods,
Elizabeth Petzold,
Aaron Schmidt,
I-Ting Teng,
Tongqing Zhou,
Peter D. Kwong,
John R. Mascola,
Barney S. Graham,
Ian N. Moore,
Robert A. Seder,
Hanné Andersen,
Mark G. Lewis,
David C. Montefiori,
Gregory D. Sempowski,
Ralph S. Baric,
Priyamvada Acharya,
Barton F. Haynes,
Kevin O. Saunders
Publication year - 2021
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/tj07-s761
Subject(s) - virology , in vivo , antibody , in vitro , neutralizing antibody , covid-19 , biology , microbiology and biotechnology , chemistry , immunology , medicine , genetics , infectious disease (medical specialty) , pathology , disease